Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Venus Remedies Ltd

VENUSREM.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$18.67

▲ +3.05%

Market Cap $249.59M · Vol 61.64K

Key Metrics

P/E Ratio

20.50

FWD: 49.50

Market Cap

$249.59M

Micro Cap

Div Yield

0.56%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

66.92

Momentum

Beta

1.02

vs Market

52W High

$21.42

13.65% below

52W Low

$4.44

287.96% above

Volume

61.64K

Avg 53.77K

P/B

1.65

Price-to-book

ROE

N/A

Return on equity

Free Float

51.38%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Venus Remedies Ltd (VENUSREM.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does VENUSREM.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+15.67%

-5.99%

+90.05%

+141.53%

YTD

+132.62%

+276.17%

+473.06%

+252.30%

Financials & Valuation

TTM · Annual

Total Revenue	$82.35M
Net Income	$11.00M
Revenue Growth (YoY)	+35.60%
Gross Margin	42.87%
Operating Margin	15.80%
Net Profit Margin	13.36%
ROE	N/A
ROA · ROIC	17.10% · 16.60%

P/E Ratio	20.50
Forward P/E (FY1)	49.50
PEG Ratio	0.08
P/S	1.42
P/B	1.65
P/FCF	9.16
EPS Growth	N/A
Outstanding Shares	13.37M

Technical Indicators

50-Day SMA	$17.87
200-Day SMA	$10.85
RSI (14)	66.92
Beta	1.02
52-Week High	$21.42
52-Week Low	$4.44

Volume Today	61.64K
Avg Daily Volume (30D)	53.77K
Relative Volume	1.15x
Volatility (10D)	41.30
Volatility (30D)	52.43
Free Float	51.38%

Analyst Consensus

N/A

Current Price $18.67

Mean Target N/A

52W Low$4.44 52W High$21.42

Current

Target

$4.44 $21.42

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S8H8T2

ISININE411B01019

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Venus Remedies Limited is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The Company operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. It has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.